Frequently Asked Questions
Yes, Suboxone and Subutex may be used for pain management.
Both Subxone and Subutex have high affinities for MU pain receptors in the body, which are responsible for pain perception.
The FDA has approved Subutex for some pain control / conditions.
Buprenorphine is FDA-approved for acute pain, chronic pain, and opioid dependence.
A doctor must have an X Drug Enforcement Administration (DEA) License number in order to prescribe Buprenorphine.
Suboxone and Subutex are used to treat Opioid dependence and pain.
The FDA (Food and Drug Administration), has approved Buprenorphine for pain management.
Buprenorphine is a partial opioid agonist.
Opioid drugs, including buprenorphine, are commonly used to treat neuropathic pain, and are considered effective.
Buprenorphine is a separate medication from oxycodone.They are two different medication.
Many patients report that Suboxone improves their mood. The FDA has not approved it as an Anti-depressent.
Buprenorphine (including Subutex) Buprenorphine is a class C, schedule 3 drug. Possession is illegal without prescription and carries a maximum sentence of 2 years’ imprisonment and a fine.
MAT stands for Medication Assisted Treatment. Opioid treatments with Suboxone is Medication Assisted Treatment.
If your addiction specialist doctor feels your taking Suboxone or Subutex is indicated, then you should consider taking it.
Buprenorphine is a semisynthetic opioid. As a derivative of thebaine, buprenorphine was controlled in Schedule II of the CSA in 1970 and remained in Schedule II during its research and development for marketing.
Schedule III: buprenorphine products, such as Buprenex, Suboxone and Subutex.
Medication-assisted treatment (MAT) is the use of medications in combination with counseling and behavioral therapies, which is effective in the treatment of opioid use disorders (OUD) and can help some people to sustain recovery.
Medication assisted treatment is an evidence–based approach to treating opioid use disorders with one of three medications approved by the U.S. Food and Drug Administration: buprenorphine, methadone and naltrexone.